I have 22 consecutive profitable trades of 15% or better. How is this possible? Every day there are hundreds of stocks setting new highs, no matter what happens in the overall market. Many of these stocks are still at very reasonable valuations. Afraid of buying stocks at their highs? Think of it this way: a new high is really a future floor for companies with solid financial underpinnings. Quantitative momentum modeling makes it easy to identify stocks that can continue this upward momentum trend. Why does this happen? It's really very simple..ask me about what investors and cows have in common. I am $$$ MR. MARKET $$$. I AM HUGE!!! Bring me your finest meats and cheeses. You can join in on the fun. Register for free and you'll be able to post messages on this forum and also receive emails when $$$ MR. MARKET $$$ makes his own trades. ($$$MR. MARKET$$$ is a proprietary investor and does not provide individual financial advice. The stocks mentioned on this forum do not represent individual buy or sell recommendations and should not be viewed as such. Individual investors should consider speaking with a professional investment adviser before making any investment decisions.)
If this is your first visit, be sure to
check out the FAQ by clicking the
link above. You may have to register
before you can post: click the register link above to proceed. To start viewing messages,
select the forum that you want to visit from the selection below.
You seem to have taken a liking to WITS. I've had my eye on it for a while but missed my entry points.. THe NAZ is approaching overdue for a correction. I wait for this pattern twice every year as we have a major slumping Gold market and a rising stock market.. WIth all the uncertainty in the world and rising terrorist attacks in spain look out for the next naz correction to spring gold high.
Bought DROOY today will sell for a .20 cent gain. Do the math on $50 000
You seem to have taken a liking to WITS. I've had my eye on it for a while but missed my entry points.. THe NAZ is approaching overdue for a correction. I wait for this pattern twice every year as we have a major slumping Gold market and a rising stock market.. WIth all the uncertainty in the world and rising terrorist attacks in spain look out for the next naz correction to spring gold high.
Bought DROOY today will sell for a .20 cent gain. Do the math on $50 000
Yes...I like WITS and HANS intermediate term...I really shoulda held WITS on Fri.
I agree...there will be a NAZ correction...but I do not think it will be below 1995 now.
"Trade What Is Happening...Not What You Think Is Gonna Happen"
Three I was watching...YIKES!!!...I did catch a nice gain on FMTI in Feb and it was on my morning watch today...but I think I'll be dead long before they ever get rid of cholesterol now...
BRKT...Brooktrout warned that it now expects first-quarter results to come in lower than previously expected, saying customers were reassessing their inventory levels and slowing their expenditures. The communications systems provider said it expects to post breakeven results or a "small profit" on sales of $18.1 million to $18.3 million, vs. a prior forecast for earnings of $500,000 to $1 million on sales of $21 million to $22.5 million. For the second quarter, Brooktrout said it expects to post breakeven results on sales of $18.5 million to $19.5 million. Brooktrout shares lost 29 percent to change hands for $15.91 in late trade.
OMCL...Omnicell, maker of procurement and inventory-management software used by hospitals and nursing homes, on Monday said it expects first-quarter earnings of 7 or 8 cents a share, based on sales of $27.5 million to $28 million. Analysts polled by Thomson First Call had been expecting earnings of 12 cents a share, based on sales of $30 million, on average. The company said that its order backlog in the period increased $4 million from the previous quarter to $42 million. Omnicell shares were last changing hands for $15.75, down 23 percent.
FMTI...But topping the volume leaders were shares of Forbes Medi-Tech. The Canadian firm said that a Phase II clinical trial of its FM-VP4 cholesterol-lowering drug found that the treatment was only 11 percent more effective in reducing low-density lipoprotein cholesterol than a placebo. The company said it was "encouraged" enough to pursue further development of the drug. Forbes Medi-Tech shares were last trading for $3.85, a 45.5-percent plunge.
"Trade What Is Happening...Not What You Think Is Gonna Happen"
Comment